Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Empros Pharma AB

Closing information (x1000 NOK)

Closing information 2024/12 2023/12 2022/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 0 More Arrow 1 Less Arrow 0
Earnings before taxes -11,999 More Arrow -10,465 More Arrow -8,681
EBITDA -12,484 More Arrow -11,839 More Arrow -8,715
Total assets 133,629 More Arrow 149,185 Less Arrow 72,518
Current assets 8,210 More Arrow 34,024 Less Arrow 7,459
Current liabilities 1,110 More Arrow 7,226 Less Arrow 4,517
Equity capital 132,520 More Arrow 141,959 Less Arrow 68,002
- share capital 268 Less Arrow 182 Less Arrow 147
Employees (average) 8 Equal arrow 8 Less Arrow 7

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 99.2% Less Arrow 95.2% Less Arrow 93.8%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -9.0% More Arrow -7.0% Less Arrow -12.0%
Current ratio 739.6% Less Arrow 470.9% Less Arrow 165.1%
Return on equity (ROE) -9.1% More Arrow -7.4% Less Arrow -12.8%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 0 More Arrow 1 Less Arrow 0
Chg. No. of employees % 0% More Arrow 14% Less Arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.